El futuro del medicamento en Europa
El Global
El pasado jueves celebramos el final del año del 25 aniversario de Faus Moliner en un acto en el Real Casino de Madrid. Mantuvimos un interesante diálogo sobre el futuro del medicamento en Europa con Maria Jesús Lamas, César Hernández y Rui Santos Ivo, acompañados de más de 150 otros amigos que nos honraron con... Read More
Price increases of medicinal products that are not reimbursed
The Judgment of the High Court of Justice of Madrid of 10 May 2023 limits the authority of the administration in this matter
Capsulas Nº 239
Background This judgement deals with the power of the Ministry of Health to oppose, based on Article 93 of the Law on Guarantees and Rational Use of Medicines and Healthcare Products (LGURMPS), the price increase of a medicinal product that is not reimbursed by the National Health System (NHS). In our opinion, this is one... Read More
The reimbursed price fixed by the government (PVL) is considered a trade secret
Judgment of the High Court of Justice of the Canary Islands of 28 March 2023
Capsulas Nº 239
Background In 2021, the Hospital Dr. Negrín of Gran Canaria started a procurement process for the supply of the active principles dupilumab and sarilumab by means of a negotiated procedure without publicity for exclusivity reasons. The dupilumab lot was not awarded. However, in the award resolution for the sarilumab lots, not only the information related... Read More
Revision of the price of public contracts for the supply and digitisation of notarial and registry proceedings
Law 11/2023 amends various relevant regulations, including the Public Sector Contracts Law, the Notaries Law, the Commercial Code and the Spanish Companies Act
Capsulas Nº 239
Background On 9 May, Law 11/2023 was published in the Official State Gazette (BOE), amending more than 20 laws, regulations and royal decrees, impacting issues as diverse as public procurement, mortgage legislation and other civil and commercial laws. Among them are the Notaries Law, the Commercial Code and the Spanish Companies Act, with significant implications... Read More
What you should know about the future EU AI Act (and why it matters to you)
In its 14 June session, the European Parliament takes a step towards comprehensive regulation on artificial intelligence
Capsulas Nº 239
Focus on people Putting humans at the heart of artificial intelligence (AI). This is the goal set by the European Parliament. On 14 June, the plenary of the European Parliament approved the proposal for a regulation establishing harmonised rules on artificial intelligence. This milestone comes after the Internal Market Committee (IMCO) and the Civil Liberties... Read More
Who is the apparent producer?
Judgment of the Provincial Court of Santa Cruz de Tenerife of 24 February 2023
Capsulas Nº 239
Litigation related to certain medical devices is generating interesting judgments that bring clarity to the concepts that serve to define the liability of economic operators involved in the manufacture and marketing of a product. Apparent producer concept One of these concepts is that of the apparent producer of a product. Legislation defines an apparent producer... Read More
Faus Moliner, Best Life Sciences Law Firm and and Best Boutique Law Firm in Spain at the VIII edition of Expansión Jurídico Awards 2023
The awards ceremony took place at the Duques de Pastrana Complex in Madrid on June 22
We are delighted to share the exciting news that Faus Moliner has received two prestigious Expansion Juridico Awards 2023: At the gala dinner held in Madrid, Faus Moliner was represented by Lluis Alcover, partner of the firm since January 2023, and by senior associate Juan Martínez. We have received numerous awards in the past years,... Read More
Faus Moliner participates in “Chambers Global Practices Guides Medical Cannabis & Cannabinoid Regulation 2023”
Anna Gerboles writes about the regulation of medical cannabis and cannabinoids in Spain
CHAMBERS GLOBAL PRACTICE GUIDES
The guide on the regulation of medical cannabis and cannabinoids 2023 provides easily accessible content on the legal framework, cross-jurisdictional rules and future developments in the regulation of medical cannabis and cannabinoids in Spain.
Quién decide qué y cómo
El Global
Los días 19 y 20 de junio se celebró el V Foro de Comisiones de Farmacia y Terapéutica organizado por FUINSA en el que Jordi Faus participó como ponente en la mesa titulada “Las CFT ante los medicamentos no financiados”. Se abordó el rol de las Comisiones de Farmacia desde diferentes perspectivas, así como cuestiones... Read More
The Pharma Legal Handbook: Spain
Faus & Moliner has participated in the publication of the Spanish chapter of the The Pharma Legal Handbook guide, edited by PharmaBoardroom
THE PHARMA LEGAL HANDBOOK
The Pharma Legal Handbook is a guide that offers a practical view, in a question and answer format, to essential questions about the legal and regulatory environment applicable to medicinal products in Spain, in areas such as regulation, pricing and reimbursement, clinical trials, manufacturing, marketing and advertising of medicinal products, product liability and trademarks and... Read More